CEA-CD3 Bispecific Antibody Cibisatamab with or Without Atezolizumab in Patients with CEA-positive Solid Tumours: Results of Two Multi-Institutional Phase 1 Trials
NATURE COMMUNICATIONS(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined